Alessandro Rambaldi
Alessandro Rambaldi
Professore di Ematologia, Universitŕ degli Studi di Milano
Verified email at unimi.it
Title
Cited by
Cited by
Year
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM Van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, ...
Leukemia 13 (12), 1901-1928, 1999
13321999
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
N Engl J Med 369, 111-121, 2013
9312013
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
MS Topp, N Gökbuget, AS Stein, G Zugmaier, S O'Brien, RC Bargou, ...
The Lancet Oncology 16 (1), 57-66, 2015
7522015
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
J Golay, L Zaffaroni, T Vaccari, M Lazzari, GM Borleri, S Bernasconi, ...
Blood, The Journal of the American Society of Hematology 95 (12), 3900-3908, 2000
7142000
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ...
New England Journal of Medicine 376 (9), 836-847, 2017
6502017
Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
Italian Cooperative Study Group on Chronic Myeloid Leukemia
New England Journal of Medicine 330 (12), 820-825, 1994
5581994
Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood 110 (3), 840-846, 2007
5162007
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
J Golay, M Lazzari, V Facchinetti, S Bernasconi, G Borleri, T Barbui, ...
Blood 98 (12), 3383-3389, 2001
4842001
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874-1881, 2013
4582013
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
A Tefferi, P Guglielmelli, DR Larson, C Finke, EA Wassie, L Pieri, ...
Blood 124 (16), 2507-2513, 2014
4102014
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice
M Morigi, M Introna, B Imberti, D Corna, M Abbate, C Rota, D Rottoli, ...
Stem cells 26 (8), 2075-2082, 2008
4022008
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
R Bassan, O Spinelli, E Oldani, T Intermesoli, M Tosi, B Peruta, G Rossi, ...
Blood 113 (18), 4153-4162, 2009
3962009
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood 120 (26), 5128-5133, 2012
3702012
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
A Carobbio, G Finazzi, V Guerini, O Spinelli, F Delaini, R Marchioli, ...
Blood 109 (6), 2310-2313, 2007
3692007
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned
S Viviani, PL Zinzani, A Rambaldi, E Brusamolino, A Levis, V Bonfante, ...
New England Journal of Medicine 365 (3), 203-212, 2011
3672011
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, ...
Leukemia 24 (3), 521-535, 2010
3612010
Prospective identification of high-risk polycythemia vera patients based on JAK2 V617F allele burden
AM Vannucchi, E Antonioli, P Guglielmelli, G Longo, A Pancrazzi, ...
Leukemia 21 (9), 1952-1959, 2007
3582007
Recombinant human interleukin 5 is a selective eosinophil chemoattractant
JM Wang, A Rambaldi, A Biondi, ZG Chen, CJ Sanderson, A Mantovani
European journal of immunology 19 (4), 701-705, 1989
3471989
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic …
P Corradini, A Dodero, F Zallio, D Caracciolo, M Casini, M Bregni, F Narni, ...
Journal of Clinical Oncology 22 (11), 2172-2176, 2004
3172004
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among …
RM Emanuel, AC Dueck, HL Geyer, JJ Kiladjian, S Slot, S Zweegman, ...
Journal of Clinical Oncology 30 (33), 4098, 2012
3052012
The system can't perform the operation now. Try again later.
Articles 1–20